Hims & Hers Health (HIMS) reported Q3 earnings late Monday of $0.32 per diluted share, swinging from a loss of $0.04 a year earlier.
Analysts polled by Capital IQ expected EPS of $0.05.
Revenue in the quarter ended Sept. 30 was $401.6 million, up from $226.7 million a year earlier.
Analysts surveyed by Capital IQ expected $382.8 million.
The company expects Q4 revenue of between $465 million and $470 million. Analysts expect $421.1 million.
For full-year 2024, it now expects revenue between $1.46 billion and $1.47 billion. The company was previously looking at full-year revenue of $1.37 billion to $1.40 billion. Analysts expect $1.4 billion.
Price: 20.50, Change: +0.14, Percent Change: +0.69
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。